Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 8


89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.

Holland JP, Divilov V, Bander NH, Smith-Jones PM, Larson SM, Lewis JS.

J Nucl Med. 2010 Aug;51(8):1293-300. doi: 10.2967/jnumed.110.076174. Epub 2010 Jul 21.


Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer.

Ghosh A, Heston WD.

J Cell Biochem. 2004 Feb 15;91(3):528-39. Review.


124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.

Sundaresan G, Yazaki PJ, Shively JE, Finn RD, Larson SM, Raubitschek AA, Williams LE, Chatziioannou AF, Gambhir SS, Wu AM.

J Nucl Med. 2003 Dec;44(12):1962-9.


Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer.

Feneley MR, Jan H, Granowska M, Mather SJ, Ellison D, Glass J, Coptcoat M, Kirby RS, Ogden C, Oliver RT, Badenoch DF, Chinegwundoh FI, Nargund VH, Paris AM, Britton KE.

Prostate Cancer Prostatic Dis. 2000 Jul;3(1):47-52.


Evaluation of preoperative ProstaScint scans in the prediction of nodal disease.

Ponsky LE, Cherullo EE, Starkey R, Nelson D, Neumann D, Zippe CD.

Prostate Cancer Prostatic Dis. 2002;5(2):132-5.


Transport of molecules, particles, and cells in solid tumors.

Jain RK.

Annu Rev Biomed Eng. 1999;1:241-63. Review.


In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen.

Smith-Jones PM, Vallabahajosula S, Goldsmith SJ, Navarro V, Hunter CJ, Bastidas D, Bander NH.

Cancer Res. 2000 Sep 15;60(18):5237-43.


Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase).

Luthi-Carter R, Barczak AK, Speno H, Coyle JT.

J Pharmacol Exp Ther. 1998 Aug;286(2):1020-5.

Supplemental Content

Support Center